Claire Irvine

Of Counsel, Beck Greener LLP. From her first days in the patent profession, Claire has been involved with many of the major innovations in the life sciences’ field. These have spanned immunotherapeutics including both therapeutic antibodies and engineered T cells, RNA therapeutics, synthetic biology, liquid biopsy for foetal and cancer diagnosis and microbiome-related developments in the medical field. In recent years, Claire has been much involved with developments in the gene-editing field, especially applications of CRISPR-Cas technology, both therapeutic and diagnostic, and has advised many on the complexities of the CRISPR IP landscape.